Altre lingue Ibnsina Pharma

Azioni

ISPH

EGS512O1C012

Prezzo di chiusura Egyptian Exchange Altri mercati azionari 00:00:00 02/05/2024			Variaz. 5gg	Var. 1 gen.
2,46 ^EGP	+1,23%		-4,65%	-21,66%

03/03	Ibnsina Pharma riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Ibnsina Pharma riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	03/03
Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	05/02
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/08/23
Ibnsina Pharma(CASE:ISPH) dropped from EGX 30 Index	02/08/23
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023	23/05/23
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022	01/03/23
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
Ibnsina Pharma(CASE:ISPH) dropped from S&P Global BMI Index	19/09/22
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	14/08/22
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022	22/05/22
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.	22/05/22
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021	23/03/22
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	14/11/21
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	16/08/21
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021	01/06/21
Ibnsina Pharma Announces Board Changes	04/04/21
Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO	04/04/21
Ibnsina Pharma Reports Earnings Results for the Full Year 2020	04/04/21
Ibn Sina Pharma (S.A.E) Announces Audited Standalone Earnings Results for the Full Year Ended December 31, 2020	01/03/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ibnsina Pharma

Azioni

ISPH

EGS512O1C012

Altre lingue

Filtri